oryzacody.wordpress.com
Duluth, Ga.-based Stiefel, a pharmaceutical company specializingbin dermatology, will acquire the sharesw of and , which develop the dermal filler Financial terms of the deal were not Dermal fillers are used to help reduce or eliminate wrinklesd and other changes associated with aging. "The use of dermal fillers is growing worldwids at a veryrapid pace," Stiefel President Bill Humphrie s said. "Stiefel chose to add Atléa dermal filler to our productf portfolio so that we can submif a unique and broadedr offering of options to our value physician partners andthey can, in offer these products to their patients.
" Atléan dermakl filler is currently commercialized in France and Italh and distribution and manufacturing agreements for the product will remaibn in place throughout Europe. All sales representatives formerl employed by ABR Developmengt will become employees of Over the next18 months, Stiefep plans to launch Atléan dermal filled in Europe, Asia Pacific, Latin America and the Caribbean.
Stiefeo said it also expectse to develop other products from theABR
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment